HQ Function

The headquarters serves as the central hub for corporate operations, research and development (R&D), clinical development, and strategic planning for its allogeneic cell therapy programs.

Notable Features:

The facility includes state-of-the-art research laboratories, process development labs, and office spaces designed to foster innovation in cell therapy. While a separate manufacturing facility exists, the HQ is critical for early-stage R&D and process optimization.

Work Culture:

The work culture at Allogene Therapeutics is characterized by a strong emphasis on scientific innovation, collaboration, patient focus, and a fast-paced environment typical of clinical-stage biotechnology companies aiming to bring novel therapies to market.

HQ Significance:

The South San Francisco headquarters is strategically important due to its location within a leading global biotech cluster, providing access to talent, research institutions, and a network of collaborators. It's the nerve center for advancing the company's AlloCAR T™ platform.

Values Reflected in HQ: The headquarters' focus on cutting-edge science and development infrastructure reflects Allogene's commitment to innovation, scientific excellence, and its mission to deliver transformative therapies to cancer patients.

Location:

Allogene Therapeutics's primary operations are based in the United States, with its headquarters and R&D in South San Francisco and manufacturing in Newark, CA. Its global presence is mainly characterized by the conduct of multi-center clinical trials for its AlloCAR T™ candidates, which may involve sites across North America, Europe, and potentially other regions as its programs advance. The company also engages in global collaborations for research and technology access.

Street Address:

210 East Grand Avenue

City:

South San Francisco

State/Province:

CA

Country:

USA